Estradiol is the most potent form of estrogen your body naturally produces. Often abbreviated as E2, it’s the primary estrogen driving reproductive function during the years between puberty and menopause, with blood levels ranging from 20 to 750 pg/mL depending on where you are in your menstrual cycle. It’s also used as a prescription medication to treat menopause symptoms and prevent bone loss.
How Estradiol Fits Among the Three Estrogens
Your body makes three types of estrogen, and they aren’t interchangeable. Estradiol is the strongest of the three. Estrone (E1) is weaker and becomes the dominant estrogen after menopause. Estriol (E3) is the weakest, barely detectable in non-pregnant women but produced in large quantities by the placenta during pregnancy.
During the reproductive years, estradiol is produced primarily by the ovaries, specifically by cells surrounding the developing egg follicle. It controls ovulation, drives the development of female sex characteristics, and sends feedback signals to the brain that regulate the entire reproductive cycle. When estradiol surges to its peak of 250 to 500 pg/mL just before ovulation, that spike is the signal triggering the release of an egg.
What Estradiol Does in the Body
Estradiol works by binding to estrogen receptors found throughout the body. There are two main types of these receptors, and they respond differently. One type is more powerful at switching genes on, while the other has a subtler effect. In tissues that carry both types, the combination creates a wider range of responses than either receptor could produce alone. This is why estradiol influences so many different systems beyond reproduction.
Its effects reach well beyond the ovaries and uterus. Estradiol helps maintain bone density, influences cholesterol levels, affects skin elasticity, and plays a role in brain function. It supports serotonin activity in the brain, which connects it to mood regulation, cognition, and emotional well-being. Higher estrogen levels have been associated with less depression in older adults of both sexes.
Estradiol in Men
Men produce estradiol too, though in much smaller amounts. Testosterone is converted into estradiol through a process called aromatization, and this conversion turns out to be essential rather than incidental. Estradiol in men helps regulate libido, erectile function, and sperm production.
The relationship between estradiol and sexual desire in men depends heavily on testosterone levels. In men with low testosterone, estradiol appears to help sustain sex drive. One notable case involved a man who lacked the enzyme to convert testosterone to estradiol: he needed both hormones to maintain normal libido, and neither one alone was enough. Research has found that in men with testosterone below 300 ng/dL, sexual drive was markedly higher when estradiol levels were above 5 ng/dL. In men with normal testosterone, though, adding extra estradiol doesn’t seem to help and may actually decrease sexual interest.
Normal Levels and How They Change
Estradiol levels fluctuate dramatically throughout the menstrual cycle. During the follicular phase (the first half of the cycle), levels typically sit between 20 and 350 pg/mL. They climb to a midcycle peak of 150 to 750 pg/mL just before ovulation, then settle into a range of 30 to 450 pg/mL during the luteal phase (the second half).
After menopause, estradiol drops to less than 10 pg/mL. That sharp decline is responsible for the hot flashes, night sweats, vaginal dryness, and bone loss that many women experience. The ovaries essentially stop producing estradiol, and the body relies on the much weaker estrone, produced mainly by fat tissue, as its primary estrogen.
Estradiol as a Medication
Prescription estradiol is FDA-approved to relieve moderate to severe menopause symptoms, including hot flashes, night sweats, vaginal dryness, and pain during sex. It can also reduce the risk of osteoporosis. It comes in several forms: oral tablets, skin patches, gels, and sprays. The patch, gel, and spray deliver estradiol through the skin directly into the bloodstream, bypassing the liver.
The doses needed for symptom relief are relatively low. Oral estradiol is typically prescribed at 0.5 to 2 mg daily, while patches deliver 14 to 50 micrograms. Ultra-low-dose formulations (0.5 mg oral or 14 microgram patches) can still provide meaningful benefits for symptoms and bone protection. Women who still have a uterus need to take a progestogen alongside estradiol to protect the uterine lining from overgrowth.
For women starting hormone therapy after age 60, current guidelines from the International Menopause Society recommend very low doses, ideally delivered through the skin rather than taken orally, to minimize side effects. The transdermal route is particularly preferred for women who are obese or have a history of blood clots. There’s no fixed rule for how long treatment should last. The decision to continue is based on an individual assessment of ongoing benefits versus risks.
Risks of Estradiol Therapy
Estradiol therapy is not without trade-offs. The Women’s Health Initiative, one of the largest studies on hormone therapy, found that estrogen combined with a progestogen increased the risk of cardiovascular events by 13% over about five and a half years. Estrogen alone carried an 11% increase over seven years. The most pronounced risks involved blood clots in the lungs and legs, and stroke. During the first year of combination therapy, the risk of coronary heart disease jumped by 80%, though it leveled off or decreased in subsequent years.
These risks apply across demographics. Women who are obese, have diabetes, or have metabolic syndrome face elevated cardiovascular risk with hormone therapy. Younger women or those closer to menopause onset generally face a lower risk of heart attack, but they still carry increased risk for stroke and blood clots. Both combination and estrogen-only therapy also increased rates of gallbladder disease, kidney stones, and urinary incontinence, and showed adverse effects on cognitive function in older women.
Because of these findings, the FDA, the American College of Obstetricians and Gynecologists, the North American Menopause Society, and the American Heart Association all recommend using hormone therapy at the lowest effective dose for the shortest time needed to manage symptoms. It is not recommended for chronic disease prevention.